29
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Effects of Mydrin eye‐drops on central corneal thickness values in adult patients with myopia

, MD & , BSc
Pages 151-154 | Received 01 May 2016, Accepted 08 Jul 2016, Published online: 15 Apr 2021
 

Abstract

Objective

This study aimed to evaluate the effect of Mydrin eye‐drops on central corneal thickness values and investigate the duration of the effect.

Methods

In this prospective randomised self‐controlled study, we enrolled 60 myopic patients (120 eyes) undergoing corneal laser refractive surgery. The central corneal thickness was measured before and one and four hours after administration of Mydrin eye‐drops (major components are tropicamide and phenylephrine hydrochloride) using the Orbscan II anterior segment analysis system and a SP-2000P non‐contact specular microscope, respectively.

Results

Using the Orbscan II system, the baseline central corneal thickness (545 ± 27 µm) was significantly lower than that at one hour after Mydrin eye‐drop application (559 ± 31 µm; p < 0.001); it was comparable to that at four hours post‐Mydrin eye‐drop administration (544 ± 26 µm; p < 0.74). Measured by non‐contact specular microscopy, the baseline central corneal thickness (508 ± 26 µm) was significantly lower than that at one hour after Mydrin eye‐drop application (521 ± 29 µm; p < 0.001); it was comparable to that at four hours after Mydrin eye‐drop administration (506 ± 24 µm; p = 0.62). A significant difference was observed in the central corneal thickness at one and four hours after Mydrin eye‐drop application by both methods (p < 0.001). Bland–Altman plots showed agreement between the measurements by the two methods at different times.

Conclusion

Central corneal thickness increases one hour after topical application of Mydrin eye‐drops and is normalised at four hours following the administration of the drops. For patients scheduled to undergo excimer laser corneal refractive surgery, the central corneal thickness should be measured before or four hours after administration of Mydrin eye‐drops.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.